









Markets
/
Stocks
/
nasdaq-embc
/

Embecta Corp

EMBC

13.420USD

0.0000.00%

Close 11/03, 16:00（ET）Quotes delayed by 15 min

784.71MMarket Cap

9.39P/E TTM



Embecta Corp

13.420

0.0000.00%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Embecta Corp

Currency: USD Updated: 2025-11-03

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Embecta Corp's Score

Industry at a Glance

Industry Ranking

61 / 210

Overall Ranking

154 / 4617

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 4 analysts

Hold

Current Rating

16.667

Target Price

+24.94%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Embecta Corp Highlights

StrengthsRisks

Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 45.72%.

Undervalued

The company’s latest PE is 9.34, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 60.03M shares, decreasing 5.12% quarter-over-quarter.

Held by Keeley-Teton Advisors, LLC

Star Investor Keeley-Teton Advisors, LLC holds 317.48K shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-03

The company's current financial score is 9.32, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 295.50M, representing a year-over-year increase of 8.44%, while its net profit experienced a year-over-year increase of 209.52%.

Score

Industry at a Glance

Previous score

9.32

Change



Financials

7.23

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

9.47

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

9.92

Key Metrics

Free cash flow

No Data

Embecta Corp's Company Valuation

Currency: USD Updated: 2025-11-03

The company’s current valuation score is 5.97, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 9.34, which is 169.66% below the recent high of 25.18 and 28.61% above the recent low of 6.67.

Score

Industry at a Glance

Previous score

5.97

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 61/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-03

The company’s current earnings forecast score is 6.50, which is lower than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for Embecta Corp is 14.00, with a high of 25.00 and a low of 11.00.

Score

Industry at a Glance

Previous score

6.50

Change

Support & Resistance

No Data

Analyst Rating

Based on 4 analysts

Hold

Current Rating

16.667

Target Price

+24.94%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

110

Total

Median

Average

Company name

Ratings

Analysts

Embecta Corp

EMBC

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-03

The company’s current price momentum score is 6.11, which is lower than the Healthcare Equipment & Supplies industry's average of 6.72. Sideways: Currently, the stock price is trading between the resistance level at 14.30 and the support level at 12.78, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.09

Change

0.02

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.119

Sell

RSI(14)

41.617

Neutral

STOCH(KDJ)(9,3,3)

22.866

Neutral

ATR(14)

0.501

Low Volatility

CCI(14)

-144.577

Sell

Williams %R

74.342

Sell

TRIX(12,20)

-0.108

Sell

StochRSI(14)

16.115

Oversold

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

13.606

Sell

MA10

13.912

Sell

MA20

13.790

Sell

MA50

14.261

Sell

MA100

12.604

Buy

MA200

13.006

Buy

Institutional Confidence

Currency: USD Updated: 2025-11-03

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.39. The latest institutional shareholding proportion is 102.64%, representing a quarter-over-quarter increase of 3.07%. The largest institutional shareholder is The Vanguard, holding a total of 5.40M shares, representing 9.24% of shares outstanding, with 23.10% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

8.03M

-3.36%

The Vanguard Group, Inc.

Star Investors

5.40M

-19.01%

American Century Investment Management, Inc.

5.20M

+36.25%

River Road Asset Management, LLC

3.24M

+0.38%

Deerfield Management Company, L.P.

2.75M

+1.07%

State Street Investment Management (US)

2.40M

+0.64%

Yacktman Asset Management LP

Star Investors

2.37M

+0.68%

William Blair Investment Management, LLC

1.99M

+0.72%

Millennium Management LLC

1.82M

+105.75%

Geode Capital Management, L.L.C.

1.51M

+3.05%

Risk Assessment

Currency: USD Updated: 2025-11-03

The company’s current risk assessment score is 5.27, which is higher than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 1.06. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.